SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-17-014414
Filing Date
2017-11-21
Accepted
2017-11-21 16:08:07
Documents
2
Period of Report
2017-11-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1751
2 POWER OF ATTORNEY ex24bazemore.txt EX-24.1 4759
  Complete submission text file 0001179110-17-014414.txt   7871
Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Issuer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DYAX CORP. 55 NETWORK DRIVE BURLINGTON MA 01803
Business Address
Bazemore Todd (Reporting) CIK: 0001605767 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38150 | Film No.: 171216923